Across TCGA pan-cancer cohorts, ZSCAN30 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated ZSCAN30 data layer compared with 23 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher ZSCAN30 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated ZSCAN30 expression acts as an unfavorable survival marker, although some lineages such as UCEC and GBM show a favorable association.

UCEC and GBM are the cancer types where ZSCAN30 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	All	1.000	0.802	.037	2	view →
GBM	OS	Median	All	0.499	0.240	.033	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: ZSCAN30 tumor-vs-normal RNA expression · all ZSCAN30 data types